Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

Anti-Human HHLA2 Antibody (2D3), FITC

Catalog #:   FHK29411 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG2a
Applications: ELISA, FCM
Accession: Q9UM44
Overview

Catalog No.

FHK29411

Species reactivity

Human

Host species

Mouse

Isotype

IgG2a

Clonality

Monoclonal

Conjugation

FITC

Applications

ELISA, FCM

Target

HHLA2, HERV-H LTR-associating protein 2, Human endogenous retrovirus-H long terminal repeat-associating protein 2

Concentration

0.5 mg/ml

Endotoxin level

Please contact with the lab for this information.

Accession

Q9UM44

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300.

Stability and Storage

Store at 4°C for 12 months. Protect from light. Do not freeze.

Clone ID

2D3

Note

For research use only.

Data Image
References

The methyltransferase METTL3 promotes tumorigenesis via mediating HHLA2 mRNA m6A modification in human renal cell carcinoma., PMID:35794583

KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy., PMID:35933091

HHLA2 predicts improved prognosis of anti-PD-1/PD-L1 immunotherapy in patients with melanoma., PMID:36003385

Novel immune scoring dynamic nomograms based on B7-H3, B7-H4, and HHLA2: Potential prediction in survival and immunotherapeutic efficacy for gallbladder cancer., PMID:36159808

Single-cell RNA sequencing highlights the functional role of human endogenous retroviruses in gallbladder cancer., PMID:36374772

Protocol for evaluating antitumor activity of KIR3DL3 blockade in an NK cell-based xenogeneic lung tumor model., PMID:36386885

The Correlation of Ten Immune Checkpoint Gene Expressions and Their Association with Gastric Cancer Development., PMID:36430322

B7 Family Members in Pancreatic Ductal Adenocarcinoma: Attractive Targets for Cancer Immunotherapy., PMID:36499340

Silencing tumor-intrinsic HHLA2 potentiates the anti-tumoral effect of paclitaxel on MG63 cells: Another side of immune checkpoint., PMID:36535461

Increased co-expression of stromal HHLA2 and fibroblast activation protein in upper tract urothelial carcinoma., PMID:36598731

Construction and Validation of a Novel Immune Checkpoint-Related Model in Clear Cell Renal Cell Carcinoma., PMID:36618968

Immunosuppression by Inflammation-Stimulated Amplification of Myeloid-Derived Suppressor Cells and Changes in Expression of Immune Checkpoint HHLA2 in Chronic Obstructive Pulmonary Disease., PMID:36846109

Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma., PMID:36899373

Overexpression and Role of HHLA2, a Novel Immune Checkpoint, in Colorectal Cancer., PMID:36982953

Transcriptome profiling reveals transcriptional regulation of VISTA in T cell activation., PMID:37004501

HHLA2 immune-regulatory roles in cancer., PMID:37011487

Recent advancements in the B7/CD28 immune checkpoint families: new biology and clinical therapeutic strategies., PMID:37069229

A new prediction model of hepatocellular carcinoma based on N7-methylguanosine modification., PMID:37081394

The Identification and Clinical Value Evaluation of CYCS Related to Asthma through Bioinformatics Analysis and Functional Experiments., PMID:37091894

Presence of PD-1 similarity genes in monocytes may promote the development of type 1 diabetes mellitus and poor prognosis of pancreatic cancer., PMID:37130628

Downregulation of HHLA2 inhibits ovarian cancer progression via the NF-κB signaling pathway and suppresses the expression of CA9., PMID:37210768

CancerHERVdb: Human Endogenous Retrovirus (HERV) Expression Database for Human Cancer Accelerates Studies of the Retrovirome and Predictions for HERV-Based Therapies., PMID:37255431

B7-H7: A potential target for cancer immunotherapy., PMID:37290327

Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells., PMID:37390222

Heterogeneous Expression of PD-L1, B7x, B7-H3, and HHLA2 in Pulmonary Sarcomatoid Carcinoma and the Related Regulatory Signaling Pathways., PMID:37444481

Role of Next Generation Immune Checkpoint Inhibitor (ICI) Therapy in Philadelphia Negative Classic Myeloproliferative Neoplasm (MPN): Review of the Literature., PMID:37569880

Analysis of a new therapeutic target and construction of a prognostic model for breast cancer based on ferroptosis genes., PMID:37643511

MUC16 stimulates neutrophils to an inflammatory and immunosuppressive phenotype in ovarian cancer., PMID:37644468

Regulation of HHLA2 expression in kidney cancer and myeloid cells., PMID:37891555

Seven chromatin regulators as immune cell infiltration characteristics, potential diagnostic biomarkers and drugs prediction in hepatocellular carcinoma., PMID:37903974

Novel immune checkpoint targets: A promising therapy for cancer treatments., PMID:37979454

Alternative immune checkpoints in immunoregulatory profile of cancer stem cells., PMID:38144305

Evaluation of HHLA2 and CD8 Immunohistochemical Expression in Colorectal Carcinoma and Their Prognostic Significance., PMID:38156868

Clinical Significance of HHLA2 as a Novel Therapeutic Target for Colorectal Cancer., PMID:38299402

HHLA2 is more significantly associated with poor prognosis in TSCC than PD-L1., PMID:38321252

The B7:CD28 family and friends: Unraveling coinhibitory interactions., PMID:38354702

Pharmacological suppression of HHLA2 glycosylation restores anti-tumor immunity in colorectal cancer., PMID:38522775

Down-regulated HHLA2 enhances neoadjuvant immunotherapy efficacy in patients with non-small cell lung cancer (NSCLC) with chronic obstructive pulmonary disease (COPD)., PMID:38553708

A radiomics signature derived from CT imaging to predict MSI status and immunotherapy outcomes in gastric cancer: a multi-cohort study., PMID:38561648

HHLA2 promotes hepatoma cell proliferation, migration, and invasion via SPP1/PI3K/AKT signaling pathway., PMID:38578157

Clinical Value of Human Endogenous Retrovirus-H Long Terminal Repeat Associating 2 (HHLA2) in Small Cell Lung Cancer., PMID:38613340

Prognostic Value of HHLA2 in Patients with Solid Tumors: A Meta-Analysis., PMID:38731979

HHLA2 deficiency inhibits pancreatic cancer progression and THP-1 macrophage M2 polarization via EGFR/MAPK/ERK and mTOR/AKT pathway., PMID:38762741

The Importance of HHLA2 in Solid Tumors-A Review of the Literature., PMID:38786018

Aberrant expression of B7-H4 and B7-H5 contributes to the development of cutaneous squamous cell carcinoma., PMID:38850312

Human endogenous retrovirus-H long terminal repeat-associating 2: an emerging immune checkpoint for cancer immunotherapy., PMID:38973642

HLA and KIR genetic association and NK cells in anti-NMDAR encephalitis., PMID:39050850

Correct stimulation of CD28H arms NK cells against tumor cells., PMID:39101623

Unlocking the potential of HHLA2: identifying functional immune infiltrating cells in the tumor microenvironment and predicting clinical outcomes in laryngeal squamous cell carcinoma., PMID:39105870

Multiplexed Spatial Imaging at the Single-Cell Level Reveals Mutually Exclusive Expression of B7 Family Proteins., PMID:39244158

Datasheet
$ 225
Product specifications
50 T 225 100 T 372

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human HHLA2 Antibody (2D3), FITC [FHK29411]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only